Norman Schwartz has literally grown up in the executive suite of Bio-Rad Laboratories. He says he doesn’t remember, but there is a family story about his crib being in the back of the company’s offices.

Today, Schwartz, 54, the son of Bio-Rad Laboratories founders David and Alice Schwartz, is the CEO and president of the 4,800-employee company, which was founded in 1957.

BioCommerce Week spoke to Schwartz this week at the JPMorgan Healthcare Conference in San Francisco about his vision for Bio-Rad’s strategy for growth.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

An artificial intelligence-based analysis suggests a third group of ancient hominins likely interbred with human ancestors, according to Popular Mechanics.

In Science this week: reduction in bee phylogenetic diversity, and more.

The New York Times Magazine looks into paleogenomics and how it is revising what's know about human history, but also possibly ignoring lessons learned by archaeologists.

The Economist reports on Synthorx's efforts to use expanded DNA bases they generated to develop a new cancer drug.